Stock Ideas
New
StocksFundsScreenerSectorsWatchlists
CYAN

CYAN - Cyanotech Corp Stock Price, Fair Value and News

0.29USD-0.01 (-3.33%)Market Closed

Market Summary

CYAN
USD0.29-0.01
Market Closed
-3.33%

CYAN Stock Price

View Fullscreen

CYAN RSI Chart

CYAN Valuation

Market Cap

2.0M

Price/Earnings (Trailing)

-0.43

Price/Sales (Trailing)

0.09

EV/EBITDA

-1

Price/Free Cashflow

-11.16

CYAN Price/Sales (Trailing)

CYAN Profitability

EBT Margin

-20.48%

Return on Equity

-33.37%

Return on Assets

-16.94%

Free Cashflow Yield

-8.96%

CYAN Fundamentals

CYAN Revenue

Revenue (TTM)

22.5M

Rev. Growth (Yr)

-5.25%

Rev. Growth (Qtr)

-12.41%

CYAN Earnings

Earnings (TTM)

-4.6M

Earnings Growth (Yr)

-70.57%

Earnings Growth (Qtr)

-27.98%

Breaking Down CYAN Revenue

Last 7 days

-3.3%

Last 30 days

-35.6%

Last 90 days

-62.3%

Trailing 12 Months

-70.4%

How does CYAN drawdown profile look like?

CYAN Financial Health

Current Ratio

1.44

Debt/Equity

0.07

Debt/Cashflow

-0.18

CYAN Investor Care

Shares Dilution (1Y)

9.80%

Diluted EPS (TTM)

-0.74

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202323.2M21.6M22.8M22.5M
202236.0M33.7M29.5M25.9M
202132.3M34.0M34.8M37.3M
202031.9M31.2M32.1M31.5M
201930.2M31.1M31.9M29.3M
201834.1M32.5M31.4M32.2M
201732.0M33.5M31.7M33.3M
201631.8M31.6M32.9M33.0M
201533.8M33.8M34.3M32.2M
201428.2M29.4M30.0M32.3M
201327.6M27.5M27.9M28.1M
201224.6M25.2M26.1M26.7M
201116.8M18.9M21.1M23.9M
201015.7M16.0M16.3M16.6M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Cyanotech Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 08, 2024
custer matthew keith
acquired
-
-
33.00
president and ceo
Apr 08, 2024
nordin amy beth
sold (taxes)
-5.2
0.4
-13.00
vp, hr, secretary
Apr 08, 2024
hartmann charles jason
sold (taxes)
-5.6
0.4
-14.00
vp, sales & marketing
Apr 08, 2024
ladin felicia i
sold (taxes)
-5.2
0.4
-13.00
cfo, vp fin & admin, treasurer
Apr 08, 2024
jensen glenn
acquired
-
-
33.00
vp, operations
Apr 08, 2024
johansen jennifer m.
acquired
-
-
33.00
vp, quality, regulatory & govt
Apr 08, 2024
cysewski gerald r
acquired
-
-
33.00
-
Apr 08, 2024
johansen jennifer m.
sold (taxes)
-5.2
0.4
-13.00
vp, quality, regulatory & govt
Apr 08, 2024
nordin amy beth
acquired
-
-
33.00
vp, hr, secretary
Apr 08, 2024
ladin felicia i
acquired
-
-
33.00
cfo, vp fin & admin, treasurer

1–10 of 50

Which funds bought or sold CYAN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 01, 2024
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
sold off
-
-
-
-%
Apr 26, 2024
Coastline Trust Co
sold off
-100
-73,336
-
-%
Mar 11, 2024
VANGUARD GROUP INC
added
1.41
5,335
47,006
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
176
176
-%
Feb 14, 2024
CITADEL ADVISORS LLC
sold off
-100
-9,619
-
-%
Feb 14, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
new
-
11,256
11,256
-%
Feb 13, 2024
RENAISSANCE TECHNOLOGIES LLC
reduced
-3.15
9,000
131,000
-%
Feb 13, 2024
GEODE CAPITAL MANAGEMENT, LLC
unchanged
-
1,369
24,000
-%
Feb 13, 2024
BlackRock Inc.
unchanged
-
967
9,577
-%
Feb 13, 2024
Tower Research Capital LLC (TRC)
reduced
-1.33
177
1,988
-%

1–10 of 13

Are Funds Buying or Selling CYAN?

Are funds buying CYAN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CYAN
No. of Funds

Unveiling Cyanotech Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Dec 20, 2023
davis michael a /
19.7%
1,356,894
SC 13D/A
Aug 30, 2023
ginungagap foundation
6.6%
424,621
SC 13D/A
Aug 29, 2023
davis michael a /
13.2%
856,503
SC 13D/A
Aug 29, 2023
ginungagap foundation
6.6%
424,621
SC 13D
Apr 02, 2021
meridian ohc partners, lp
3.7%
227,258
SC 13D/A
Mar 10, 2021
wells fargo & company/mn
0.00%
18
SC 13G/A
Dec 02, 2020
davis michael a /
15.04%
1,175,827
SC 13D/A
Feb 04, 2020
wells fargo & company/mn
6.34%
375,150
SC 13G

Recent SEC filings of Cyanotech Corp

View All Filings
Date Filed Form Type Document
Apr 10, 2024
4
Insider Trading
Apr 10, 2024
4
Insider Trading
Apr 10, 2024
4
Insider Trading
Apr 10, 2024
4
Insider Trading
Apr 10, 2024
4
Insider Trading
Apr 10, 2024
4
Insider Trading
Apr 10, 2024
4
Insider Trading
Apr 09, 2024
25-NSE
25-NSE
Feb 27, 2024
4
Insider Trading
Feb 21, 2024
4
Insider Trading

Peers (Alternatives to Cyanotech Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
29.3B
91.7B
-5.55% -20.28%
9.62
0.32
-10.07% -31.73%
14.7B
61.3B
-2.52% 13.20%
7.7
0.25
-8.91% 30.43%
14.6B
12.1B
5.23% -18.71%
15.36
1.21
-0.78% 18.26%
13.4B
9.3B
4.52% -17.39%
17.47
1.44
1.02% -5.78%
11.9B
79.2B
-3.11% -0.87%
9.16
0.15
2.05% -14.37%
MID-CAP
7.5B
1.7B
0.33% 57.42%
45.56
4.34
21.49% 39.64%
5.3B
766.9M
-1.68% 59.30%
-157.91
6.92
28.82% 43.50%
5.2B
5.1B
7.61% -12.63%
42.48
1.03
5.93% -45.96%
2.8B
3.3B
2.93% 39.02%
20.94
0.85
0.37% -0.15%
2.8B
2.4B
-6.98% 16.64%
10.03
1.16
-22.17% -63.60%
SMALL-CAP
1.9B
14.8B
0.73% 53.82%
18.91
0.13
-14.86% -22.80%
894.7M
2.1B
2.71% -25.96%
-13.52
0.43
-4.65% -482.22%
532.9M
343.4M
8.85% -35.78%
-1.58
1.55
-18.04% 7.65%
216.6M
106.3M
-2.07% 24.54%
4.52
2.04
34.67% 5930.90%
7.6M
2.5M
-0.51% 264.81%
-0.28
3.07
-21.18% -24.37%

Cyanotech Corp News

Latest updates
Yahoo Finance • 2 months ago
Simply Wall St • 2 months ago
Simply Wall St • 4 months ago

Cyanotech Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-12.4%5,5826,3735,1465,3925,8915,1796,7168,1269,4599,4198,9649,4386,9858,5717,3528,6347,5047,6908,0716,05910,044
Gross Profit-21.0%1,6492,0881,5321,3871,7641,7902,3182,8943,2383,7623,6722,7712,0713,3012,9753,0842,8773,0633,6762,2294,116
Operating Expenses-8.2%2,4972,7202,7412,6412,1682,6272,7432,5302,7302,6803,0532,7952,5123,0192,7072,8572,5102,6543,6263,5503,621
  S&GA Expenses0.1%1,3871,3851,2761,3991,0411,1421,1681,1051,1271,1311,5501,6001,3001,3741,2441,6011,4061,3431,4081,7342,068
  R&D Expenses-6.9%163175191213106206246229200127156120211173135121146154187288216
EBITDA Margin-26.2%-0.10*-0.08*-0.10*-0.05*0.01*0.04*0.09*0.12*0.10*0.12*0.10*0.10*---------
Interest Expenses5.5%17216316016918610344.0080.0011610195.00176123121131127164182185168134
Income Taxes-100.0%-2.00-7.008.00-3.007.006.0011.004.00--2.006.00-1.00-19.5032.00-1.00-3.00-16.0073.00
Earnings Before Taxes-28.3%-1,020-795-1,369-1,423-590-940-469285392981524-200825161137102203227-136-1,489361
EBT Margin-11.8%-0.20*-0.18*-0.20*-0.15*-0.07*-0.02*0.04*0.06*0.05*0.06*0.04*0.03*---------
Net Income-28.0%-1,020-797-1,369-1,430-598-940-472278386970520-200827155138121171228-133-1,473288
Net Income Margin-11.6%-0.21*-0.18*-0.20*-0.15*-0.07*-0.03*0.03*0.06*0.04*0.06*0.04*0.03*---------
Free Cashflow-219.9%-1,000834-596583-223-1,161-1,2991,0359182,284-1,8581,481---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-2.9%27.0028.0029.0030.0030.0030.0031.0032.0031.0031.0031.0031.0031.0033.0033.0032.0032.0032.0034.0030.0030.00
  Current Assets-3.2%12.0013.0013.0013.0015.0015.0015.0016.0016.0015.0016.0015.0015.0017.0016.0015.0015.0014.0015.0015.0014.00
    Cash Equivalents-46.5%1.001.001.001.001.000.001.003.002.002.001.004.003.004.003.002.002.001.001.001.002.00
  Inventory-4.9%9.0010.0011.0011.0012.0012.0011.009.009.0010.009.008.0010.0010.0010.0010.0011.0011.0012.0011.0010.00
  Net PPE-3.2%10.0011.0011.0011.0012.0012.0012.0012.0012.0012.0012.0012.0012.0013.0013.0013.0013.0014.0014.0015.0015.00
Liabilities-1.9%13.0014.0014.0013.0012.0012.0012.0013.0012.0012.0014.0014.0014.0017.0017.0016.0017.0017.0018.0015.0013.00
  Current Liabilities-1.4%9.009.009.008.005.005.004.005.005.005.006.006.007.008.007.006.007.007.008.009.008.00
  Short Term Borrowings-1.00--------------------
  Long Term Debt0%1.001.001.001.004.004.004.004.004.004.005.005.004.006.006.006.006.006.007.005.00-
    LT Debt, Non Current0%1.001.001.001.004.004.004.004.004.004.005.005.004.006.006.006.006.006.007.005.00-
Shareholder's Equity-4.0%14.0014.0015.0016.0018.0018.0019.0019.0019.0019.0018.0017.0017.0016.0016.0016.0016.0015.0015.0015.0016.00
  Retained Earnings-5.2%-20.82-19.80-19.00-17.63-16.20-15.61-14.67-14.19-14.47-14.86-15.83-16.35-16.15-16.98-17.13-17.27-17.39-17.56-17.79-17.65-16.18
  Additional Paid-In Capital1.3%35.0034.0034.0034.0034.0034.0034.0034.0034.0033.0033.0033.0033.0033.0033.0033.0033.0033.0033.0032.0032.00
Shares Outstanding6.4%7.006.006.006.006.006.006.006.006.006.006.006.00---------
Float------8.00---11.00---7.00---8.00---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-219.9%-1,000834-596583-223-1,161-1,2991,0359182,284-1,8581,481-2221,287-1461,039783294-873-8051,271
  Share Based Compensation-69.1%54.0017547.0044.0045.0019922.0026.0019899.0021.0018.0018.0016810.0018531.0020.0034140.0038.00
Cashflow From Investing72.8%-37.00-136-150-50.00-328-314-376-525-224-350-171-177-288-164-131-44.00-94.00-38.00-48.00-56.00-137
Cashflow From Financing520.0%462-110420-72.006851,117-177-219-530-861-677-859-421-1951,185-187-174-2171,136128-224
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CYAN Income Statement

2023-12-31
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Net sales$ 5,582,000$ 5,891,000$ 17,101,000$ 17,786,000
Cost of sales3,933,0004,127,00011,831,00011,914,000
Gross profit1,649,0001,764,0005,270,0005,872,000
Operating expenses:    
General and administrative947,0001,021,0003,381,0003,631,000
Sales and marketing1,387,0001,041,0004,048,0003,351,000
Research and development163,000106,000530,000556,000
Total operating expenses2,497,0002,168,0007,959,0007,538,000
Loss from operations(848,000)(404,000)(2,689,000)(1,666,000)
Interest expense, net(172,000)(186,000)(495,000)(333,000)
Loss before income taxes(1,020,000)(590,000)(3,184,000)(1,999,000)
Income tax expense08,0002,00011,000
Net loss$ (1,020,000)$ (598,000)$ (3,186,000)$ (2,010,000)
Net loss per share:    
Basic (in dollars per share)$ (0.16)$ (0.1)$ (0.5)$ (0.32)
Diluted (in dollars per share)$ (0.16)$ (0.1)$ (0.5)$ (0.32)
Shares used in calculation of net loss per share:    
Basic (in shares)6,5546,2726,4046,235
Diluted (in shares)6,5546,2726,4046,235

CYAN Balance Sheet

2023-12-31
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Dec. 31, 2023
Mar. 31, 2023
Current assets:  
Cash$ 661,000$ 974,000
Accounts receivable, net of allowance for credit losses of $11 as of December 31, 2023 and $64 as of March 31, 20232,036,0001,331,000
Inventories9,124,00010,707,000
Prepaid expenses and other current assets464,000484,000
Total current assets12,285,00013,496,000
Equipment and leasehold improvements, net10,434,00011,366,000
Operating lease right-of-use assets, net4,409,0004,776,000
Other assets126,00090,000
Total assets27,254,00029,728,000
Current liabilities:  
Accounts payable1,389,0001,021,000
Accrued expenses753,0001,101,000
Customer deposits70,00089,000
Operating lease obligations, current portion517,000483,000
Short term debt - bank1,360,0000
Line of credit – bank01,540,000
Line of credit – related party1,250,000500,000
Current maturities of long-term debt3,199,0003,369,000
Total current liabilities8,538,0008,103,000
Long-term debt, less current maturities1,000,0001,000,000
Long-term operating lease obligations3,883,0004,275,000
Other long-term liabilities03,000
Total liabilities13,421,00013,381,000
Commitments and contingencies
Stockholders’ equity:  
Preferred stock of $0.01 par value, authorized 10,000,000 shares; no shares issued and outstanding00
Common stock of $0.02 par value, authorized 50,000,000 shares; issued and outstanding 6,886,600 shares at December 31, 2023 and 6,271,971 shares at March 31, 2023138,000125,000
Additional paid-in capital34,515,00033,856,000
Accumulated deficit(20,820,000)(17,634,000)
Total stockholders’ equity13,833,00016,347,000
Total liabilities and stockholders’ equity$ 27,254,000$ 29,728,000
CYAN
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. The company was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
 CEO
 WEBSITEcyanotech.com
 INDUSTRYPackaged Foods
 EMPLOYEES86

Cyanotech Corp Frequently Asked Questions


What is the ticker symbol for Cyanotech Corp? What does CYAN stand for in stocks?

CYAN is the stock ticker symbol of Cyanotech Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cyanotech Corp (CYAN)?

As of Fri May 03 2024, market cap of Cyanotech Corp is 2 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CYAN stock?

You can check CYAN's fair value in chart for subscribers.

What is the fair value of CYAN stock?

You can check CYAN's fair value in chart for subscribers. The fair value of Cyanotech Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cyanotech Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CYAN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cyanotech Corp a good stock to buy?

The fair value guage provides a quick view whether CYAN is over valued or under valued. Whether Cyanotech Corp is cheap or expensive depends on the assumptions which impact Cyanotech Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CYAN.

What is Cyanotech Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 03 2024, CYAN's PE ratio (Price to Earnings) is -0.43 and Price to Sales (PS) ratio is 0.09. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CYAN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cyanotech Corp's stock?

In the past 10 years, Cyanotech Corp has provided -0.246 (multiply by 100 for percentage) rate of return.